EJMI. 2018; 2(2): 101-103 | DOI: 10.14744/ejmi.2018.76376

Metastatic Renal Cell Carcinoma: A Case Report of Multiple Treatment Options and a Review of the Literature

Mahmut Buyuksimsek¹, Ismail Oguz Kara¹, Abdullah Evren Yetisir¹, Cem Mirili¹, Serkan Gokcay¹, Ali Ogul¹, Mert Tohumcuoglu¹, Hilmi Erdem Sumbul², Kubra Buyuksimsek^3
1Department of Oncology, Cukurova University Faculty of Medicine, Adana, Turkey, ²Department of Internal Medicine, Health Science Universty, Adana City Training and Research Hospital, Adana, Turkey, ³Department of Children Emergency, Seyhan State Hospital, Adana, Turkey

Renal cell carcinoma (RCC), the most common type of kidney cancer, may present in many different clinical forms. The treatment order to be given in cases of RCC, for which there are several alternative therapies, has become an important issue. A patient diagnosed with RCC in 2009 was treated with interferon, sorafenib, everolimus, nivolumab, and axitinib for 7 years. This patient was followed up for 4 years after the detection of hepatic metastasis; this patient was the first at this center to receive cytokine treatment, tyrosine kinase inhibitor, and immunotherapy with axitinib, consecutively.

---

Cite This Article

Buyuksimsek M, Kara I, Yetisir A, Mirili C, Gokcay S, Ogul A, Tohumcuoglu M, Sumbul H, Buyuksimsek K. Metastatic Renal Cell Carcinoma: A Case Report of Multiple Treatment Options and a Review of the Literature. EJMI. 2018; 2(2): 101-103

Corresponding Author: Mahmut Buyuksimsek

Full Text PDF PDF Download